Alpha Cognition (ACOG) Cash & Equivalents (2023 - 2025)
Alpha Cognition's (ACOG) quarterly Cash & Equivalents came in at $66.0 million in Q4 2025, up 36.05% year-on-year from $48.5 million in Q4 2024, and up 86.58% quarter-over-quarter from $35.4 million in Q3 2025.
Alpha Cognition (ACOG) Cash & Equivalents (2023 - 2025) Analysis & Trends
Alpha Cognition's Cash & Equivalents history runs 3 years deep, the most recent figure standing at $66.0 million for Q4 2025.
- On a quarterly basis, Cash & Equivalents rose 36.05% year-over-year to $66.0 million in Q4 2025; TTM through Dec 2025 was $66.0 million, a 36.05% increase from a year earlier, with the FY2025 full-year figure at $66.0 million, up 36.05% from the prior year.
- Cash & Equivalents rose to $66.0 million in Q4 2025 per ACOG's latest filing, from $35.4 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $66.0 million in Q4 2025 and bottomed at $1.0 million in Q2 2024.
- The 3-year median for Cash & Equivalents is $37.4 million (2025), against an average of $30.1 million.
- Biggest YoY gain for Cash & Equivalents was 3767.57% in 2025; the steepest drop was 36.05% in 2025.
- Year by year, Cash & Equivalents stood at $1.4 million in 2023, then soared by 3357.31% to $48.5 million in 2024, then surged by 36.05% to $66.0 million in 2025.
- Per Business Quant, the three latest ACOG Cash & Equivalents figures stand at $66.0 million (Q4 2025), $35.4 million (Q3 2025), and $39.4 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 82.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.49 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 3.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 440.94 Mn |
| 10 | Alpha Cognition | 145.51 Mn | 79.41 Mn | 2.61 Mn | 66.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66.05 Mn |
| Sep 30, 2025 | 35.40 Mn |
| Jun 30, 2025 | 39.41 Mn |
| Mar 31, 2025 | 45.53 Mn |
| Dec 31, 2024 | 48.55 Mn |
| Sep 30, 2024 | 3.67 Mn |
| Jun 30, 2024 | 1.02 Mn |
| Dec 31, 2023 | 1.40 Mn |